Urology Practice Management - Web Exclusives
The addition of abiraterone acetate (Zytiga) to androgen-deprivation therapy (ADT) did not increase medical resource utilization in patients with metastatic castration-naïve prostate cancer who participated in the multinational LATITUDE clinical trial.
According to the results of 2 separate clinical trials presented at the 2018 Genitourinary Cancers Symposium, apalutamide and enzalutamide reduced the risk for metastasis and prolonged metastasis-free survival in patients with nonmetastatic castrate-resistant prostate cancer.
Adding Antiandrogen Therapy to Radiation Improves Survival in Recurrent Prostate Cancer—A New Standard of Care?
“This study’s findings—that adding antiandrogen therapy to the radiation typically used against recurrence reduces the incidence of metastasis, death from prostate cancer and overall deaths—will change the standard of care for patients experiencing a postoperative recurrence,” Dr Shipley added.
The Office of Civil Rights (OCR) has begun stepping up efforts to ensure that covered entities are in compliance with HIPAA regulations. OCR audits are typically conducted is response to a complaint. In order to be compliant, practices should have policies in place regarding the treatment of all health information containing individually identifiable information. The policy should extend to electronic as well as written information.
To maintain pace with the ongoing IT revolution, practices must find cost-effective solutions for purchasing and implementing electronic technologies. There a number of funding options available to finance investments in technology. These investments may include consulting, hardware, software, and training. It may be helpful to speak with other practices in your area to learn from their experiences.
Results 1 - 8 of 8